Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

Fang Liu, MD PhD, Hongyu Zhang, MD PhD, Xiao Wang, MD PhD, Yisong Xiong, PhD, Yuanzhen Cao, Yi Su, MD, Hai Yi, MD PhD, Jia Feng, MD PhD, Wenli Zhang, MD, Yu Ma, Masayuki Wada, PhD, Yupo Ma, MD PhD

Blood (2019) 134 (Supplement_1): 38.

https://doi.org/10.1182/blood-2019-122964

Published: 2019

Journal Articles

First-in-Human CD4 CAR Clinical Trial on Peripheral T-Cell Lymphoma

Hongyu Zhang, MD PhD, Jia Feng, MD PhD, Wenli Zhang, MD, Qi Chen, PhD, Yuanzhen Cao, Kevin Pinz, Fang Liu, MD PhD, Yu Ma, Masayuki Wada, PhD, Yupo Ma, MD PhD

Blood (2019) 134 (Supplement_1): 2881.

https://doi.org/10.1182/blood-2019-122789

Published: 2019

Journal Articles

First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

Fang Liu, MD PhD, Yuanzhen Cao, Kevin Pinz, Yu Ma, Masayuki Wada, PhD, Kevin Chen, Gina Ma, Jiaqi Shen, Charlotte Olivia Tse, Yi Su, MD, Yisong Xiong, PhD, Guangcui He, MD, Yecheng Li, MD, Yupo Ma, MD PhD

Blood (2018) 132 (Supplement 1): 901.

https://doi.org/10.1182/blood-2018-99-110579

Published: 2018

Journal Articles

Hepcidin in Male Double Red Blood Cell Donors - Relationship Between Parameters of Iron Metabolism and Erythropoiesis

Shuo Wang, Huihui Li, MS, Lisa Sarran, Gordana Olbina, PhD, Mark Westerman, PhD, Elizabeta Nemeth, PhD, Eric E. Bouhassira, PhD, Tomas Ganz, MD, PhD, Yelena Ginzburg, MD

Blood (2011) 118 (21): 2109.

https://doi.org/10.1182/blood.V118.21.2109.2109

Published: 2011

Journal Articles

Genetic manipulation of AML1-ETO–induced expansion of hematopoietic precursors in a Drosophila model

Sergey A. Sinenko, Tony Hung, Tatiana Moroz, Quynh-Minh Tran, Sohrab Sidhu, Matthew D. Cheney, Nancy A. Speck, Utpal Banerjee

Blood (2010) 116 (22): 4612–4620.

https://doi.org/10.1182/blood-2010-03-276998

Published: 2010

Includes: Supplemental data

NARROW

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

First-in-Human CD4 CAR Clinical Trial on Peripheral T-Cell Lymphoma

First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

Hepcidin in Male Double Red Blood Cell Donors - Relationship Between Parameters of Iron Metabolism and Erythropoiesis

Genetic manipulation of AML1-ETO–induced expansion of hematopoietic precursors in a Drosophila model

Email alerts

ASH Publications

American Society of Hematology

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

First-in-Human CD4 CAR Clinical Trial on Peripheral T-Cell Lymphoma

First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

Hepcidin in Male Double Red Blood Cell Donors - Relationship Between Parameters of Iron Metabolism and Erythropoiesis

Genetic manipulation of AML1-ETO–induced expansion of hematopoietic precursors in a Drosophila model

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only